Effect of Bicalutamide Combined with Docetaxel on Serum PSA and VEGF Levels in Patients with Advanced Prostate Carcinoma

Table 3

Incidence of toxic and side effects ((%)).

Groups		Gastrointestinal reactions	Abnormal liver function	Sexual dysfunction	Sensory abnormalities	Total incidence
Experimental group	45	2 (4.44%)	1 (2.22%)	1 (2.22%)	2 (4.44%)	6 (13.33%)
Control group	45	4 (8.89%)	3 (6.67%)	3 (6.67%)	4 (8.89%)	14 (31.11%)
						4.114
						<0.05